Global Cytocentrifuge Industry is poised to surpass the US$ 2.1 Billion mark by 2033, driven by escalating demand for point-of-care testing, according to FMI
The global cytocentrifuge industry growth is projected to be worth US$ 1.3 billion in 2023, poised to reach a substantial value of US$ 2.1 Billion by 2033, according to comprehensive industry analysis. With an anticipated Compound Annual Growth Rate (CAGR) of 4.5% throughout the forecast period, this market demonstrates consistent and promising growth potential. Factors…